Endothelial dysfunction and cardiovascular diseases: The role of human induced pluripotent stem cells and tissue

Mary H C Florido1,2,3, Nicholas P Ziats1,4

  • 1Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.

Insights

Novel therapies for cardiovascular disease (CVD) are crucial. Combining stem cell biology and bioengineering advances tissue engineering for CVD treatment, mimicking native tissues for better outcomes.

Area of Science:

  • Biomedical Engineering
  • Stem Cell Biology
  • Cardiovascular Research

Background:

  • Cardiovascular disease (CVD) is the leading global cause of mortality.
  • Understanding CVD pathophysiology is vital for developing new treatments.
  • Endothelial cell dysfunction plays a significant role in CVD.

Purpose of the Study:

  • To review advancements in cardiovascular disease research.
  • To highlight the synergy between stem cell biology and bioengineering.
  • To discuss the impact on cardiovascular tissue engineering and treatment.

Main Methods:

  • Review of recent studies on CVD, endothelial cells, and dysfunction.
  • Exploration of stem cell biology techniques, including reprogramming human pluripotent stem cells.
  • Discussion of bioengineering approaches using organic and inorganic biomaterials to mimic extracellular matrix.

Main Results:

  • Stem cell technology enables generation of various cell types.
  • Biomaterials facilitate in vitro recapitulation of organ structures.
  • The integration of stem cell biology and bioengineering accelerates progress in CVD research.

Conclusions:

  • The convergence of stem cell biology and bioengineering offers significant promise for cardiovascular disease treatment.
  • Tissue engineering strategies are advancing cardiovascular device development.
  • Further research in this interdisciplinary field is essential for novel therapeutic interventions.

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
23.1K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K